GCC
GSK icon

Guardian Capital (Canada)’s GSK GSK Stock Holding History

Guardian Capital (Canada)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-54,200
Closed -$2.75M – 194
2017
Q3 		$2.75M Sell
54,200
-2,214
-4% -$112K 0.04% 118
2017
Q2 		$3.04M Sell
56,414
-2,390
-4% -$127K 0.05% 125
2017
Q1 		$3.1M Sell
58,804
-2,593
-4% -$132K 0.05% 126
2016
Q4 		$2.96M Sell
61,397
-21,613
-26% -$1.07M 0.04% 121
2016
Q3 		$4.47M Sell
83,010
-41,880
-34% -$2.3M 0.07% 110
2016
Q2 		$6.77M Buy
124,890
+2,743
+2% +$145K 0.11% 95
2016
Q1 		$6.19M Buy
122,147
+10,229
+9% +$509K 0.1% 96
2015
Q4 		$5.64M Sell
111,918
-5,611
-5% -$286K 0.11% 93
2015
Q3 		$5.65M Sell
117,529
-957
-0.8% -$49.8K 0.11% 90
2015
Q2 		$6.17M Buy
118,486
+14,552
+14% +$819K 0.1% 92
2015
Q1 		$6M Buy
103,934
+1,624
+2% +$93.1K 0.1% 90
2014
Q4 		$5.47M Sell
102,310
-4,584
-4% -$256K 0.09% 89
2014
Q3 		$6.14M Buy
106,894
+1,171
+1% +$71.8K 0.09% 88
2014
Q2 		$7.07M Sell
105,723
-8,572
-7% -$580K 0.1% 86
2014
Q1 		$7.63M Buy
114,295
+30,242
+36% +$2.04M 0.12% 81
2013
Q4 		$5.61M Buy
84,053
+21,651
+35% +$1.4M 0.09% 90
2013
Q3 		$3.91M Buy
62,402
+53,042
+567% +$3.41M 0.06% 93
2013
Q2 		$585K Buy
+9,360
New +$594K 0.01% 148

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Guardian Capital (Canada)'s GSK Position: Q4 2017 in Review

Guardian Capital (Canada) sold out of GSK (GSK) in Q4 2017, closing a stake of 54,200 shares — an estimated $2.75M sold.

Guardian Capital (Canada) first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $7.63M in Q1 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Guardian Capital (Canada) reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Guardian Capital (Canada) sold 54,200 GSK shares in Q4 2017, an estimated $2.75M.
  • Guardian Capital (Canada) first reported a position in GSK in Q2 2013 and held it in 18 quarters.
  • Guardian Capital (Canada)'s GSK position peaked at $7.63M in Q1 2014.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Guardian Capital (Canada)'s 13F filing for Q4 2017, filed 14 Feb 2018.